ClinicalTrials.Veeva

Menu

Passive Smoking and LL-37 in Children

K

Kırıkkale University

Status

Completed

Conditions

Innate Immunity
Periodontal Health

Study type

Observational

Funder types

Other

Identifiers

NCT03639376
2016/140

Details and patient eligibility

About

This study investigates the salivary LL-37 in passive smoking-exposed and unexposed children and the association between salivary LL-37 levels and periodontal clinical parameters in these children.Unstimulated salivary samples were collected from 180 children (90 passive smoking-exposed and 90 passive smoking-unexposed)

Full description

Diverse mechanisms conduce to the detrimental periodontal effects of passive smoking, including alteration of both microbial and host response factors.

Antimicrobial peptides are considered to be an important intermediate step in initiating an initial immune response against the microbial side of the oral gingival epithelium and in the transition to acquired immunity.

LL-37 has a wide antimicrobial activity against both cariogenic and periopathogenic bacteria and its role in maintaining oral health has recently been stated

Enrollment

180 patients

Sex

All

Ages

6 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Systemically healthy children

Exclusion criteria

  • Any medications known to affect defense system and periodontium
  • The presence of orthodontic / intraoral appliance

Trial design

180 participants in 2 patient groups

Passive smoking-exposed children
Description:
This group consists of children whose family members have smoked at home since the birth of the child.
Passive smoking-unexposed children
Description:
This group consists of children whose family members have not smoked at home since the birth of the child.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems